These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 27666365)
1. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression. Wang Q; Yu W; Huang T; Zhu Y; Huang C Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365 [TBL] [Abstract][Full Text] [Related]
2. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-455 regulates migration and invasion of human hepatocellular carcinoma by targeting Runx2. Qin L; Zhang Y; Lin J; Shentu Y; Xie X Oncol Rep; 2016 Dec; 36(6):3325-3332. PubMed ID: 27748890 [TBL] [Abstract][Full Text] [Related]
4. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma. Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994 [TBL] [Abstract][Full Text] [Related]
5. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling. Han S; Han L; Yao Y; Sun H; Zan X; Liu Q Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889 [TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. Li X; Yang Z; Song W; Zhou L; Li Q; Tao K; Zhou J; Wang X; Zheng Z; You N; Dou K; Li H Int J Oncol; 2013 Sep; 43(3):793-802. PubMed ID: 23807724 [TBL] [Abstract][Full Text] [Related]
8. MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9. Sun SJ; Wang N; Sun ZW; Chen J; Cui HW Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4869-4878. PubMed ID: 30070322 [TBL] [Abstract][Full Text] [Related]
9. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition. Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434 [TBL] [Abstract][Full Text] [Related]
10. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Zhang J; Zhang DL; Jiao XL; Dong Q Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232 [TBL] [Abstract][Full Text] [Related]
11. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438 [TBL] [Abstract][Full Text] [Related]
12. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma. Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205 [TBL] [Abstract][Full Text] [Related]
15. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma. Lin X; Chang W; Wang Y; Tian M; Yu Z Biomed Pharmacother; 2017 Sep; 93():398-405. PubMed ID: 28654796 [TBL] [Abstract][Full Text] [Related]
16. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Shi GM; Ke AW; Zhou J; Wang XY; Xu Y; Ding ZB; Devbhandari RP; Huang XY; Qiu SJ; Shi YH; Dai Z; Yang XR; Yang GH; Fan J Hepatology; 2010 Jul; 52(1):183-96. PubMed ID: 20578262 [TBL] [Abstract][Full Text] [Related]
17. RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9. Liu Z; Dou C; Jia Y; Li Q; Zheng X; Yao Y; Liu Q; Song T Int J Oncol; 2015 Apr; 46(4):1710-20. PubMed ID: 25626059 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
19. Distinct roles of Akt1 in regulating proliferation, migration and invasion in HepG2 and HCT 116 cells. Chen L; Kang QH; Chen Y; Zhang YH; Li Q; Xie SQ; Wang CJ Oncol Rep; 2014 Feb; 31(2):737-44. PubMed ID: 24297510 [TBL] [Abstract][Full Text] [Related]
20. Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma. You N; Tan Y; Zhou L; Huang X; Wang W; Wang L; Wu K; Mi N; Li J; Zheng L Exp Cell Res; 2017 Sep; 358(2):217-226. PubMed ID: 28663060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]